Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PepGen Inc.PEPG · Entity 6253 | Chief Medical Officer | July 24, 2024 | July 26, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PepGen Inc.
Report date July 24, 2024 · Filed July 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-07-25 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2024-07-24 · Exercise / conversion · Acquired 201 · Balance 201 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Row 2 · 2024-07-24 · Sale · Disposed 201 · Balance 0 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2024-07-25 · Exercise / conversion · Acquired 7,571 · Balance 7,571 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Row 4 · 2024-07-25 · Sale · Disposed 7,571 · Balance 0 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.21 · Expires 2032-06-30 | Direct | 57,571 |
Reported balance
After 2024-07-24 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-07-24 · Exercise / conversion · Disposed 201 · Balance 57,571 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.21 · Expires 2032-06-30 | Direct | 50,000 |
Reported balance
After 2024-07-25 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-07-25 · Exercise / conversion · Disposed 7,571 · Balance 50,000 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 25, 2024 Filed Jul 26, 2024 16:52 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,571 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-021044 · form4.xml · derivative · entry 6 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 7,571 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 16:52 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 7,571 | $18.06 | $136,741.35 |
DisclosureSEC source: 0001127602-24-021044 · form4.xml · nonDerivative · entry 4 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.37, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 16:52 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 7,571 | $10.21 | $77,299.91 |
DisclosureSEC source: 0001127602-24-021044 · form4.xml · nonDerivative · entry 3 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 16:52 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 201 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-021044 · form4.xml · derivative · entry 5 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,571 Underlying: Common Stock · 201 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 16:52 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 201 | $18.01 | $3,619.03 |
DisclosureSEC source: 0001127602-24-021044 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 24, 2024 Filed Jul 26, 2024 16:52 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 201 | $10.21 | $2,052.21 |
DisclosureSEC source: 0001127602-24-021044 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 16:09 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,625 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-020735 · form4.xml · derivative · entry 3 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,772 Underlying: Common Stock · 12,625 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 16:09 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 12,625 | $18.20 | $229,804.04 |
DisclosureSEC source: 0001127602-24-020735 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 16:09 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 12,625 | $10.21 | $128,901.25 |
DisclosureSEC source: 0001127602-24-020735 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 16, 2024 Filed Jul 16, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,901 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-020521 · form4.xml · derivative · entry 6 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,397 Underlying: Common Stock · 5,901 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 16, 2024 Filed Jul 16, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 5,901 | $18.00 | $106,246.91 |
DisclosureSEC source: 0001127602-24-020521 · form4.xml · nonDerivative · entry 4 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 16, 2024 Filed Jul 16, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 5,901 | $10.21 | $60,249.21 |
DisclosureSEC source: 0001127602-24-020521 · form4.xml · nonDerivative · entry 3 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,288 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-020521 · form4.xml · derivative · entry 5 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,298 Underlying: Common Stock · 3,288 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 3,288 | $18.04 | $59,331.30 |
DisclosureSEC source: 0001127602-24-020521 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 3,288 | $10.21 | $33,570.48 |
DisclosureSEC source: 0001127602-24-020521 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 13:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 37 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-019998 · form4.xml · derivative · entry 6 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,586 Underlying: Common Stock · 37 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 13:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 37 | $18.07 | $668.59 |
DisclosureSEC source: 0001127602-24-019998 · form4.xml · nonDerivative · entry 4 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 13:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 37 | $10.21 | $377.77 |
DisclosureSEC source: 0001127602-24-019998 · form4.xml · nonDerivative · entry 3 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 13:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 875 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-019998 · form4.xml · derivative · entry 5 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,623 Underlying: Common Stock · 875 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 13:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 875 | $18.01 | $15,759.63 |
DisclosureSEC source: 0001127602-24-019998 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 13:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 875 | $10.21 | $8,933.75 |
DisclosureSEC source: 0001127602-24-019998 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 16:26 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,260 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-019285 · form4.xml · derivative · entry 3 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,498 Underlying: Common Stock · 9,260 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 16:26 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 9,260 | $18.19 | $168,427.36 |
DisclosureSEC source: 0001127602-24-019285 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 24, 2024 Filed Jun 26, 2024 16:26 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 9,260 | $10.21 | $94,544.60 |
DisclosureSEC source: 0001127602-24-019285 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,086 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-018569 · form4.xml · derivative · entry 6 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,758 Underlying: Common Stock · 1,086 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 1,086 | $18.06 | $19,614.68 |
DisclosureSEC source: 0001127602-24-018569 · form4.xml · nonDerivative · entry 4 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 1,086 | $10.21 | $11,088.06 |
DisclosureSEC source: 0001127602-24-018569 · form4.xml · nonDerivative · entry 3 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-018569 · form4.xml · derivative · entry 5 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,844 Underlying: Common Stock · 500 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 500 | $18.04 | $9,022.00 |
DisclosureSEC source: 0001127602-24-018569 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 16:46 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 500 | $10.21 | $5,105.00 |
DisclosureSEC source: 0001127602-24-018569 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,411 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-018155 · form4.xml · derivative · entry 6 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,344 Underlying: Common Stock · 1,411 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 1,411 | $18.00 | $25,398.00 |
DisclosureSEC source: 0001127602-24-018155 · form4.xml · nonDerivative · entry 4 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 1,411 | $10.21 | $14,406.31 |
DisclosureSEC source: 0001127602-24-018155 · form4.xml · nonDerivative · entry 3 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,245 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0001127602-24-018155 · form4.xml · derivative · entry 5 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,755 Underlying: Common Stock · 7,245 shares Expires 2032-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F4 · derivative.exercise_date: This stock option vests over four years following the vesting commencement date (April 4, 2022) with 25% of such shares vesting on the first anniversary of the vesting commencement date, and the remaining shares vesting in 36 equal monthly installments, subject to continued service through each vesting date. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | SaleCommon Stock | 7,245 | $18.09 | $131,062.05 |
DisclosureSEC source: 0001127602-24-018155 · form4.xml · nonDerivative · entry 2 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:12 UTC | PepGen Inc. PEPG · Entity 6253 | Exercise / conversionCommon Stock | 7,245 | $10.21 | $73,971.45 |
DisclosureSEC source: 0001127602-24-018155 · form4.xml · nonDerivative · entry 1 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,245 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 19, 2024. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 17:29 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 83,000 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001127602-24-007942 · form4.xml · derivative · entry 1 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Stock · 83,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 16:53 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001127602-23-008414 · form4.xml · derivative · entry 2 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 20,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 16:53 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $15.25 | $0.00 |
DisclosureSEC source: 0001127602-23-008414 · form4.xml · derivative · entry 1 Mellion Michelle L · CIK 0001923040 · SVP, Clinical Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2033-02-28 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| July 01, 2022 Filed Aug 31, 2022 16:15 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $10.21 | $0.00 |
DisclosureSEC source: 0000899243-22-030121 · doc4.xml · derivative · entry 1 Mellion Michelle L · CIK 0001923040 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-06-29 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on April 4, 2023, and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
| May 06, 2022 Filed May 10, 2022 18:53 UTC | PepGen Inc. PEPG · Entity 6253 | GrantStock Option (Right to Buy) · Derivative | 16,655 | $0.00 Strike: $12.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017500 · doc4.xml · derivative · entry 1 Mellion Michelle L · CIK 0001923040 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,655 Underlying: Common Stock · 16,655 shares Expires 2032-05-05 F1 · derivative.exercise_date: This option shall vest as follows: twenty-five percent (25%) on the one-year anniversary of the Grant Date and the remainder vesting in thirty-six (36) equal monthly installments, subject to the option recipient's continued service or employment with the Company on each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.